All blog items

When the COVID-19 pandemic hit the United States in late January, and then began to impact North Carolinians in March, students, staff and faculty across the Duke University School of Medicine and Duke University Health System found their lives and daily activities upturned.  Physician-scientist trainees—residents and fellows in the School of Medicine who work as medical doctors and also research scientists—had to pivot, too, during what is often a very critical time in their careers.

The pilot project, which is funded by the NIH, creates a model with potential to expand to additional school districts across the nation.

As the 2020 freedom-vs-facemask culture war rages on in America’s social media feeds and grocery store checkout aisles, a panel of Duke experts suggests an empathetic, non-adversarial approach to get more people to cover up.

The following are links shared during the July RCA! Best Practices in Research Project and Proposal Development, presented by Dr. Michael Gunn, Professor of Medicine and Immunology.  To view this session (or other RCA! Professional Development sessions) please visit the OPSD Resource page, and choose the Research Careers Ahead! tab.

The Duke University School of Medicine is expanding into a newly-leased research center in the Research Triangle Park (RTP). The 273,000 square foot facility in the Parmer RTP research and development campus, formerly home to pharmaceutical maker GlaxoSmithKline, is currently being renovated to accommodate School of Medicine faculty, staff and labs as soon as January 2021.

What role can data science play in confronting the COVID-19 pandemic and social injustice?

              The Duke Clinical Research Training Program (CRTP) is launching an exciting new Basic Science Research Track (BSRT) developed by the School of Medicine Office of Physician Scientist development (OPSD) for their Masters of Health Sciences (MHS) degree in August of 2020.

Drs. Kevin Thomas and Oluwadamilola Fayanju spoke to and took questions from media members about reasons, possible solutions for health disparities.

Thanks to a $250,000 grant from the Antibacterial Resistance Leadership Group, the RADICAL team has shifted its focus to examine whether their host gene expression test works for patients with COVID-19.

The following are links shared during the June RCA! Navigating NIH Policies and Guidelines During COVID19, presented by Dr. Geeta Swamy, Associate Vice President for Research, Associate Vice Provost for Scientific Integrity and Associate Professor of Obstetrics and Gynecology, and Laurianne Torres, Associate Dean for Research Administration.  To view this session (or other RCA!